Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2002

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Bipolar Disorder
Interventions
DRUG

aripiprazole

Trial Locations (27)

Unknown

Local Institution, Tuscaloosa

Local Institution, Little Rock

Local Institution, Beachwood

Local Institution, Chula Vista

Local Institution, Riverside

Local Institution, San Clemente

Local Institution, San Diego

Local Institution, Stanford

Local Institution, Washington D.C.

Local Institution, North Miami

Local Institution, Winter Park

Local Institution, Honolulu

Local Institution, Chicago

Local Institution, Indianapolis

Local Institution, Louisville

Local Institution, Belmont

Local Institution, Newton Center

Local Institution, New Baltimore

Local Institution, Lawrence

Local Institution, Butner

Local Institution, Cincinnati

Local Institution, Medina

Local Institution, Philadelphia

Local Institution, Austin

Local Institution, Houston

Local Institution, Falls Church

Local Institution, Bellevue

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00036101 - Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder | Biotech Hunter | Biotech Hunter